Search by Drug Name or NDC
NDC 00143-9785-10 Valproate Sodium 500 mg/5mL Details
Valproate Sodium 500 mg/5mL
Valproate Sodium is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is VALPROATE SODIUM.
Product Information
| NDC | 00143-9785 |
|---|---|
| Product ID | 0143-9785_0610e50d-6447-4a0e-bc36-dc0bffa95c7d |
| Associated GPIs | 72500020102020 |
| GCN Sequence Number | 031533 |
| GCN Sequence Number Description | valproic acid (as sodium salt) VIAL 500 MG/5ML INTRAVEN |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 64371 |
| HICL Sequence Number | 001882 |
| HICL Sequence Number Description | VALPROIC ACID (AS SODIUM SALT) (VALPROATE SODIUM) |
| Brand/Generic | Generic |
| Proprietary Name | Valproate Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Valproate Sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/5mL |
| Substance Name | VALPROATE SODIUM |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078523 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9785-10 (00143978510)
| NDC Package Code | 0143-9785-10 |
|---|---|
| Billing NDC | 00143978510 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9785-10) / 5 mL in 1 VIAL, SINGLE-DOSE (0143-9785-01) |
| Marketing Start Date | 2010-02-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |